Evonik to supply commercial quantities of simufilam, a drug candidate for the treatment of Alzheimer’s disease. The late clinical phase quantities will be produced at Evonik’s Tippecanoe site in the US ... MORE

Evonik wins awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability and Service ... MORE

Evonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines. Commercial quantities are to be produced at Evonik’s Hanau and Dossenheim sites (Germany) as part of a partnership with BioNTech. ... MORE

Omega-3 lysine complex AvailOm® shows five times higher bioavailability than a commercially available standard oil-based ethyl-ester formulation ... MORE

LACTEL® biodegradable, PLGA-based polymers to be integrated into Evonik’s Health Care business. The acquisition was closed on December 31, 2020 ... MORE

LACTEL® brand of biodegradable, PLGA-based polymers to be integrated into Evonik’s Health Care business. The Acquisition further expands Evonik’s market-leading portfolio of functional excipients and biomaterials ... MORE